The safety and immunogenicity of inactivated hepatitis A vaccine was evaluated in patients with chronic liver disease. Sixty hepatitis A virus antibody (anti-HAV) seronegative patients with chronic liver disease (56 chronic hepatitis B and four chronic hepatitis C) and from 17 to 47 years of age rec
End-stage liver disease and liver transplantation: Role of lamivudine therapy in patients with chronic hepatitis B
β Scribed by Emmet B. Keeffe
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 135 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Frequent coinfection of surface antigen-negative hepatitis B virus (silent HBV) in hepatitis C virus (HCV)-associated chronic liver disease (CLD) has been reported. The clinical and virological significance of silent HBV infection was investigated in 65 patients with HCV-associated CLD who subsequen
## Abstract ## Objective The association of hepatitis C virus (HCV) infection with type II mixed cryoglobulinemia is well established, but the role of HCV in B cell lymphoma remains controversial. The objective of this study was to determine the frequency of circulating and liverβinfiltrating mono
Lamivudine is effective in suppressing replication of hepatitis B virus (HBV). However, the emergence of HBV variants resistant to lamivudine is a concern. Lamivudine resistance has been attributed mainly to a substitution of isoleucine or valine for methionine at residue 550 (M550I or M550V) in the